Can a med spa in Arkansas offer compounded semaglutide or tirzepatide?

Short answer
Generally no — compounding a copy of a commercially available FDA-approved drug is prohibited; a slightly different version is allowed only on a documented patient-specific need or documented unavailability, such as back-order or an FDA shortage.

Arkansas generally prohibits compounding a copy of a commercially available drug, and semaglutide and tirzepatide are commercially available products. Compounding a drug product that is commercially available in the marketplace or that is essentially a copy of a commercially available Food and Drug Administration-approved drug product is generally prohibited. (2) However, in special circumstances a pharmacist may compound an appropriate quantity of a drug that is only slightly different than a Food and Drug Administration-approved drug that is commercially available: (A) Based on documentation provided by the prescribing physician of a patient-specific medical need (e.g., the physician requests an alternate product due to hypersensitivity to excipients or preservative in the Food and Drug Administration-approved product, or the physician requests an effective alternate dosage form); or (B) If the drug product is not commercially available.

17 CAR § 160-2201(b)(1)-(2) (Standards for compounding and dispensing compounded products — copies of commercially available drugs) · verified Sep 7, 2026 · regulatory monitoring, not legal advice